Your browser doesn't support javascript.
loading
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
Heeke, Arielle L; Xiu, Joanne; Elliott, Andrew; Korn, W Michael; Lynce, Filipa; Pohlmann, Paula R; Isaacs, Claudine; Swain, Sandra M; Vidal, Gregory; Schwartzberg, Lee S; Tan, Antoinette R.
Affiliation
  • Heeke AL; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Arielle.Heeke@atriumhealth.org.
  • Xiu J; Caris Life Sciences, Inc., Phoenix, AZ, USA.
  • Elliott A; Caris Life Sciences, Inc., Phoenix, AZ, USA.
  • Korn WM; Caris Life Sciences, Inc., Phoenix, AZ, USA.
  • Lynce F; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Pohlmann PR; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Isaacs C; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Swain SM; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Vidal G; West Cancer Center and Research Institute, Germantown, TN, USA.
  • Schwartzberg LS; University of Tennessee Health Science Center, Memphis, TN, USA.
  • Tan AR; West Cancer Center and Research Institute, Germantown, TN, USA.
Breast Cancer Res Treat ; 184(2): 265-275, 2020 Nov.
Article in En | MEDLINE | ID: mdl-32776290

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2020 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2020 Type: Article Affiliation country: United States